DNA Genotek’s ORAcollect RNA kit included in EUA granted to Biocerna SARS-CoV-2 test
On May 4, 2020, DNA Genotek, a subsidiary of OraSure Technologies, announced that its ORAcollect RNA kit (OR-100)…
On May 4, 2020, DNA Genotek, a subsidiary of OraSure Technologies, announced that its ORAcollect RNA kit (OR-100)…
On May 3, 2020, the Government of Canada announced it was investing in projects that support the global…
On May 2, 2020, Roche announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency…
On May 1, 2020, Gilead announced that the U.S. Food and Drug Administration (FDA) has granted emergency use…
On May 1, 2020, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for…
On May 1, 2020, a new University of Southern California (USC) study suggests that temporarily suppressing the body’s immune…
On May 1, 2020, the U.S. Dept. of Veterans Affairs (VA) announced participation in a series of clinical…
On May 1, 2020, the Food and Drug Administration (FDA) approved daratumumab and hyaluronidase-fihj (DARZALEX FASPRO, Janssen Biotech.)…
On May 1, 2020, the U.S. Centers for Disease Control and Prevention (CDC) launched the SARS-CoV-2 Sequencing for…
On May 1, 2020, Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture…
On May 1, 2020, CHF Solutions announced that it has shipped Aquadex product to a specialty care center…
On May 1, 2020, 3M announced that it has completed the sale of substantially all of its drug delivery…
On May 1, 2020, people with cancer who develop COVID-19 are much more likely to die from the…
On May 1, 2020, XBiotech announced that human immune donors have now been identified that can support the Company’s…
On Apr. 30, 2020, the FDA included, under the ventilator emergency use authorization (EUA), a ventilator developed by…
On Apr. 30, 2020, Mesoblast announced a Phase 2/3 randomized, placebo-controlled trial to rigorously confirm whether its allogeneic…
On Apr. 30, 2020, AstraZeneca and the University of Oxford announced an agreement for the global development and…
On Apr. 30, 2020, University of Oxford announced an agreement with the UK-based global biopharmaceutical company AstraZeneca for…
On Apr. 30, 2020, Valneva and Pfizer announced a collaboration to develop and commercialize Valneva’s Lyme disease vaccine…
On Apr. 30, 2020, FUJIFILM announced that it will reserve manufacturing capacity for a future COVID-19 therapy for…
On Apr. 30, 2020, the research community reacted with alarm and anger to the National Institutes of Health’s…
On Apr. 30, 2020, the University of Oxford announced an agreement with the UK-based global biopharmaceutical company AstraZeneca…
On Apr. 30, 2020, Medigen Vaccine Biologics (MVC) announced its SARS-CoV-2 qPCR Kit complied with EU CE requirements,…
On Apr. 30, 2020, The California Institute for Regenerative Medicine (CIRM) awarded $750,000 to City of Hopeメs John…
On Apr. 30, 2020, Vaxart announced it has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with…
On Apr. 30, 2020, Mateon Therapeutics report several peer-reviewed publications derived from its R&D effort against COVID-19. Published April…
On Apr. 30, 2020, an international team of more than 120 scientists has detailed the impact of 75…
On Apr. 30, 2020, Emory University researchers are taking part in a multi-site study across the U.S. to…
On Apr. 30, 2020, Tyson announced a partnership with Matrix Medical Network to help ensure the safety and…
On Apr. 30, 2020, INOVIO announced an agreement to expand its manufacturing partnership with the German contract manufacturer…